Preoperative Screening for Hyperglycemia Risk, Preoperative CHO, and Perioperative Glucose Control. E. Patchen Dellinger, MD

Similar documents
QI Successes & Failures Learning from Both

Show Me the Evidence

Perioperative Glycemic Control Implementation

9/23/09. What are the key components of preoperative, intraoperative, & postoperative care of diabetes management? Rebecca L. Sturges, M.D.

Enhanced Recovery Beaumont Anesthesiology

What s so sweet about glycemic control? June 3, 2016

Not Too Sweet in the OR Suite: Perioperative Glucose Management Update

Basic pathophysiology of recovery: the role of endocrine metabolic response. Franco Carli McGill University Montreal, Canada

In - Hospital Diabetes Care. A review and personal experience

Reducing Colorectal Surgical Site Infections

NPO GUIDELINES: WHAT, HOW MUCH AND WHY. Janey Phelps, MD FAAP UNC Children s Hospital August 25, 2012

Quality Improvement Updates Foley Discontinuation Protocol Surgical Care Improvement Project

Perioperative pathophysiology and the objectives behind Enhanced Recovery Care

Hyperglycemia is strongly correlated with

4/7/2013. Disclosures. Learning Healthcare System in Washington State. Objectives. Improving Outcomes through Pre-hospital Checklists

Deepika Reddy MD Department of Endocrinology


How to Address an Inappropriately high Mortality Rate? Joe Sharma, MD Associate Professor of Surgery NSQIP Surgical Champion

Measure Information Form

Disclosures. Glycemic Control in the Intensive Care Unit. Objectives. Hyperglycemia. Hyperglycemia. History. No disclosures

What Should Be the Therapeutic Glycemic Target in Intensive Care Units?

Preventing Surgical Site Infections: The SSI Bundle

VANDERBILT UNIVERSITY MEDICAL CENTER MULTIDISCIPLINARY SURGICAL CRITICAL CARE TRAUMA INTENSIVE CARE UNIT GLYCEMIC CONTROL PROTOCOL

7/31/2015. Enhanced Recovery After Surgery: Change Your Mind, Change Your Practice. Objectives. Enhanced Recovery Society

123 Are You Providing Evidence-Based Diabetes Care? - Martin

GLUCOSE CONTROL IN THE SURGICAL SETTING

Malnutrition: An independent Risk Factor for Postoperative Complications

Inpatient Glycemic Management 2016

Glucose Management in NON-ICU Hospitalized Patients

PREOPERATIVE CARBOHYDRATE LOADING IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS OR SPINAL SURGERY. Susan Tran

ENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT

Best Practices for Fast Track in Bariatric Surgery: Enhanced Recovery After Bariatric Surgery

Fasting Not Starving! Dr David Rowe FANZCA VMO Anaesthetist Armidale Rural Referral Hospital Rural SIG meeting Cradle Mountain July 2015

Fluid Balance in an Enhanced Recovery Pathway. Edwin Itenberg, DO, FACS, FASCRS St. Joseph Mercy Oakland MSQC/ASPIRE Meeting April 28, 2017

Gastrointestinal Feedings Post Op: What s the deal on beginning oral feedings?

PETER J. DUNBAR, MB CHB, MBA CEO

Post operative nutritional supplementation and early feeding: an evidence based view of current treatment Steven Thomas University Hospitals Bristol

Glycemic Control Insulin In The Hospital Setting

Surgical Site Infection Prevention: International Consensus on Process

Measure Information Form

Modifiable Risk Factors in Orthopaedic Infections

Transition of Care in Hospitalized Patients with Hyperglycemia and Diabetes

PERIOPERATIVE ANESTHETIC RISK IN THE GERIATRIC PATIENT

THE USE OF INSULIN TO REDUCE SURGICAL SITE INFECTIONS (SSIS) CAPTAIN DAVID BRADLEY MAJ JASMINE HOGAN MAJ KYONG WINKLER

Managing Diabetes and Hyperglycemia Safely in the Complex Hospital Setting

HAP PA-HEN Achieving More Together

Presented By: Samik Patel MD. Martinovski M 1, Patel S 1, Navratil A 2, Zeni T 3, Jonker M 3, Ferraro J 1, Albright J 1, Cleary RK 1

Show Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital

Venous Thromboembolism Prophylaxis: Checked!

Transfusion & Mortality. Philippe Van der Linden MD, PhD

The Portland Diabetic Project: Hyperglycemia/Mortality Hypothesis

Basal Bolus Insulin Therapy Frequently Asked Questions

AMERICAN COLLEGE OF SURGEONS NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM. SAR Models. Vanessa Thompson, PhD

To staple or to sew. Zeng Xuan Hu

SCORES FOR 4 TH QUARTER, RD QUARTER, 2014

A Children s Bedtime Story

Acute Care Surgery (ACS) team approach for Benign Gallbladder Disorders (BGD) Dr. Prashanth Sreeramoju MD,

Preoperative Fasting for Patients Undergoing Elective Surgery

Inpatient Management of Hyperglycemia Guillermo Umpierrez, MD, CDE Saturday, February 10, :30 a.m. 11:15 a.m.

ACUTE ABDOMEN IN DIABETIC PATIENTS ANALYSIS OF COMPLICATIONS AND MORTALITY

Understanding the Semiannual Report (SAR),Site Summary Reports, and Model Drill Down

Surgery for patients with diffuse atherosclerotic disease

Peri-operative Glucose Control Is it Important?

Enhanced Recovery after Surgery - A Colorectal Perspective. R Sim Centre for Advanced Laparoscopic Surgery, TTSH

Perioperative Management of the Patient with Endocrine Disease: A Focus on Diabetes & Thyroid Dysfunction

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Perioperative hyperglycaemia and its treatment in patients with diabetes mellitus Polderman, J.A.W.

Blood Management of the Cardiac Patient in the Postoperative Period

SCIP Cardiac Measure. Lee A. Fleisher, M.D.

Breast Enhanced Recovery after Surgery: Improvement of Patient Experience

PRACTICE guidelines are systematically developed

Management of Inpatient Hyperglycemia: 2011 Endocrine Society Meeting Hyperglycemia in Critically ill patients in ICU Settings.

Benefits and Harms of Routine Preoperative Testing: A Comparative Effectiveness Review

Nüchternzeiten in der Kinderanästhesie nüchtern betrachtet

What is Metabolic About Metabolic Surgery? The New ADA Recommendations

Managing Perioperative Diabetes What s new? Kathryn A. Myers MD FRCPC Chair Chief Division of GIM Professor of Medicine Western University

ACS-NSQIP 2015 Julietta Chang MD, Ali Aminian MD, Stacy A Brethauer MD, Philip R Schauer MD Bariatric and Metabolic Institute

Reducing Surgical Site Infection after Major Gynecologic Cancer Surgery

Postoperative Glucose Control and SCIP Measures. Gorav Ailawadi, MD Chief, Adult Cardiac Surgery University of Virginia April 25, 2015

Special Situations 1

None. O u t l i n e. Conflict Of Interests. Reengineering in Surgical Paradigm. Patient Selection Influences Perioperative Outcome

Pre-op Clinical Triad - Pulmonary. Sammy Pedram, MD FCCP Assistant Professor of Medicine Pulmonary & Critical Care Medicine March 16, 2018

Initial Management of Septic Patients with Hyperglycemia in the Noncritical Care Inpatient Setting

Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty

Creating an Early Recovery Order Set for Colorectal Surgery-It s the Journey as well as the Destination

ADVANCES IN SURGERY INDEX. who should have or not have axillary node dissection with, 1 18

Per-Jonas Blind, Bodil Andersson, Bobby Tingstedt, Magnus Bergenfeldt, Roland Andersson, Gert Lindell, Christian Sturesson

Operational Efficiency in Colon Surgery Enhanced Recovery Pathways: 23 hour laparoscopic colectomy

Judicious Use of Preoperative Consultants. Relevant disclosures: None. Preoperative Consultation by Specialists: Overall Impact on Outcome?

Bariatric Surgery Post Op Plan PACU Phase

How to manage type 2 diabetes in medical and surgical patients in the hospital

ERAS. Presented by Timothy L. Beard MD, FACS, CPI Bend Memorial Clinic

Inpatient Management of Diabetes Mellitus. Jessica Garza, Pharm.D. PGY-1 Pharmacotherapy Resident TTUHSC School of Pharmacy

CMS Hospital IQR Program Measure Comparison Tables FY 2018 (CY 2016) Measures Required to Meet Hospital IQR APU Requirements NHSN Submission

ANNUAL MEETING 2 #FSHP2017

Expectations for Patient Centered Care

Pre-operative glucose as a screening tool in patients without diabetes

Preoperative Optimization and Surgical Site Infection Reduction

Preoperative Optimization and Surgical Site Infection Reduction

High-Risk Conventional Cardiac Surgery: Current Strategy. Disclosures: Edwards, Medtronic (Speaker)

Transcription:

Preoperative Screening for Hyperglycemia Risk, Preoperative CHO, and Perioperative Glucose Control E. Patchen Dellinger, MD

Disclosure Slide Dr. Dellinger has worked in the area of clinical trials with industry sponsorship since 1973. During the past 4 years he has received grants for clinical research from, served on an advisory board for, and/or lectured for honoraria from, Merck, Baxter, Ortho-McNeil, Targanta, Schering-Plough, Astellas, Allergan, Care Fusion, Durata, Pfizer, Applied Medical, Rib-X, Affinium, Tetraphase, Televancin, R- Pharm, Cubist, Melinta, Motif, Microdermis, and 3M. He is not a member of any speakers bureaus and has not received any company-provided speaker s training and never uses any company-provided slides or other visual materials.

Diabetes, Glucose Control, and SSIs After Median Sternotomy 20 % Infections 15 10 5 0 <200 200-249 250-299 >300 Latham. ICHE 2001; 22: 607-12

Hyperglycemia and Risk of SSI after Cardiac Operations No increased risk: Elevated HgbA1c Preoperative hyperglycemia Increased risk: Diagnosed diabetes Undiagnosed diabetes Post-op glucose > 200 mg% within 48h Latham. Inf Contr Hosp Epidemiol. 2001;22:607 Dellinger. Inf Contr Hosp Epidemiol. 2001;22:604

Hyperglycemia and Risk of SSI after Cardiac Operations Hyperglycemia - doubled risk of SSI Hyperglycemic: 48% of diabetics 12% of nondiabetics 30% of all patients 47% of hyperglycemic episodes were in nondiabetics Latham. Inf Contr Hosp Epidemiol. 2001;22:607 Dellinger. Inf Contr Hosp Epidemiol. 2001;22:604

200 Glucose Levels and Infection after CABG in NonDiabetics 180 160 140 Glucose 120 100 80 60 No infection Any infection Mediastinitis 40 20 0 0 1 2 Day Swenne. J Hosp Inf 2005; 61: 201

Hyperglycemia and Infection Does it apply only to cardiac surgery? Do WBC struggling to work in syrup know whether they are in a median sternotomy or an abdominal incision?

Early (48h) Postoperative Glucose Levels and SSI after Vascular Surgery >151 mg% <103 mg% 103-117 mg% 117-151 mg% Vriesendorp. Eur J Vasc Endovasc Surg 2004; 28:520-5

Perioperative Hyperglycemia in Noncardiac Surgical Patients Ramos. Ann Surg 2008;248: 585 591

Mastectomy, Hyperglycemia, and SSI 260 patients, 5 glucose determinations (pre-op, at anesthesia induction, intra-op, in PACU, at 24 hrs) Odds Risk Factor Ratio C.I. Age > 50 3.7 (1.5-9.2) Pre-Op ChemoRads 2.8 (1.4-5.8) Any gluc > 150 mg% 2.9 (1.2-6.2) Villar-Compte. AJIC 2008; 36:192-8

Postop Glucose (within 48h) and SSI General Surgery Glucose Ata. Arch Surg 2010: 145: 858-864

Glucose & Infection Risk Non-Cardiac Surgery & Diabetes Multivariate analysis: All the usual risk factors significant. HgbA1c NOT significant. PostOp glucose > 150 very significant. King. Ann Surg 2011; 253:158-65

Postoperative Glucose and Mortality in Noncardiac Surgery Hyperglycemia in nondiabetic patients was more dangerous than hyperglycemia in diabetics! Frisch. Diabetes Care. 2010; 33: 1883-8

Rabbit 2 Study Surgery Basal/Bolus vs Sliding Scale Insulin Basal Bolus Sliding Scale p value Patients 104 107 Mean Fasting 155 167 0.04 Mean Daily 157 176.001 Readings < 140 53% 31%.001 Wound infections 3 11.05 Any complication 9 26.003 Umpierrez. Diabetes Care 2011; 34: 256-61

Perioperative Hyperglycemia and Total Knee or Hip Arthroplasty Fasting Blood Glucose POD #1 16.0% 14.0% 12.0% Infection rate 10.0% 8.0% 6.0% 4.0% 2.0% 0.0% <100 101-200 > 200 Mraovic. J Diab Science & Technol 2011; 5: 412-8

Hgb A1c vs. Glucose as Risk Factor for SSI Gastric Bypass A1c Level n < 6.5% 310 6.5-7.9% 92 > 8% 66 Perna. Surg Obes Rel Dis 2012; 8: 685-90

Hgb A1c vs. Glucose as Risk Factor for SSI Gastric Bypass Multivariate Analysis Odds ratio = 1.27 (1.06-1.51) for every 20 mg% increase in mean glucose level during hospitalization (p=0.008). Mean glucose more significant than any level above 200 Mg% or not. Hgb A1c not significant. Perna. Surg Obes Rel Dis 2012; 8: 685-90

HgA1c and Postoperative Glucose Abdominal Surgery 80 70 Relation of Preoperative A1c to Postoperative Glucose Gluc<160 Gluc>160 60 50 40 30 20 10 0 HgA1c <5.7 5.7-6.4 6.5-7.0 >7.0 Goodenough. J Amer Coll Surg 2015; 221: 854-61

SCOAP Data on Perioperative Glucose Levels and Insulin Use 11630 patients from 2005-2010 with Bariatric operation (5360) Colectomy (6273) Who either Experienced glucose > 180 (3383) Or did not (8247) During the perioperative period or on POD 1 or POD 2 Kwon. Ann Surg. 2013; 257: 8-14

SCOAP Data on Perioperative Glucose Levels and Insulin Use Diabetic pts 4098 (35%) Hyperglycemic 2369 (58%) Nondiabetic pts 7532 (65%) Hyperglycemic 1014 (13%) 30% of all hyperglycemic patients were not diabetic! Kwon. Ann Surg. 2013; 257: 8-14

Composite Infection Hyperglycemia vs No Hyperglycemia Diabetic Patients 14 12 10 8 6 4 2 0 ** Both Ops Bariatric Colectomy * * p<0.05 ** p<0.01 Normal Gluc>180 Kwon. Ann Surg. 2013; 257: 8-14

Composite Infection Hyperglycemia vs No Hyperglycemia Nondiabetic Patients 20 15 All p<0.01 10 5 Normal Gluc>180 0 All Pts Bariatric Colectomy Kwon. Ann Surg. 2013; 257: 8-14

Composite Infection in Hyperglycemic Patients With and Without Use of Insulin Kwon. Ann Surg. 2013; 257: 8-14

Operative Reintervention in Hyperglycemic Patients With and Without Use of Insulin Kwon. Ann Surg. 2013; 257: 8-14

Mortality in Hyperglycemic Patients With and Without Use of Insulin Kwon. Ann Surg. 2013; 257: 8-14

Composite Infection in Hyperglycemic Patients Patients with glucose > 180 Odds Ratio for Infection Only D.O.S. Only POD 1 or 2 Both POD 1 & 2 1.7 2.1 3.1 Kwon. Ann Surg. 2013; 257: 8-14

S.C. vs I.V. Insulin 24 hrs PostOp Gynecologic Oncology Operations SQ I.V. Nondiab Grp 1 Diabetics, intermittent s.c. insulin Grp 2 Diabetics or any gluc >150, IV insulin Grp 3 - NonDiabetics Al-Niaimi. Gynecol Oncol 2015; 136: 71-6

S.C. vs I.V. Insulin 24 hrs PostOp Gynecologic Oncology Operations 24 h ave gluc Hypoglycemia Grp 1 (SQ) 162 mg% 5.4%% Grp 2 (I.V.) 110 mg% 0.7% P <0.01 <0.05 Grp 1 Diabetics, intermittent s.c. insulin Grp 2 Diabetics or any gluc >150, IV insulin Al-Niaimi. Gynecol Oncol 2015; 136: 71-6

Hyperglycemia Impairs Immunity Impairs Immunity Increases Collagenase Activity Impairs Leukocyte Function Impairs cardiac ischemic preconditioning Reduces collateral blood flow

Glucose Control Proven important for SSI risk: Cardiac surgery General surgery Colorectal surgery Vascular surgery Breast surgery Gynecologic Oncology surgery Hepato-pancreatico-biliary surgery Orthopedic surgery Trauma surgery

Regardless of the Diagnosis of Diabetes (or not) Hyperglycemia Increases Morbidity Mortality Length of Stay

Which Patients Are at Risk for Hyperglycemia?

Glucose in NonDiabetics having Colectomy at Cleveland Clinic Highest Gluc N (%) < 125 mg% 816 (33%) 126-200 mg% 1289 (53%) 200 mg% 342 (14%) 2/3 All patients 2447 (100%) Kiran, et al. Ann Surg 2013; 258:599-605

Glucose in NonDiabetics having Colectomy at Cleveland Clinic 8 7 *p<0.03, p<0.01, + p<0.05 Per Cent incidence 6 5 4 3 2 1 Mort+ Sepsis SSI* Reop 0 <125 126-200 >200 Kiran, et al. Ann Surg 2013; 258:599-605

Preoperative Glucose as a Screening Tool for Patients Without Diabetes Random glucose within 30 days of operation Average 8 days before operation 16% within one day and 29% within 3 days 6683 patients <70 70-99 100-139 140-179 >180 384 pts 4251 pts 1801 pts 187 pts 60 pts Wang. J Surg Res. 2014; 186: 371-8

Preoperative Glucose as a Screening Tool for Patients Without Diabetes 25 20 15 10 Infection Complication 5 0 <70 70-99 100-139 140-179 >180 Wang. J Surg Res. 2014; 186: 371-8

Preoperative Glucose as a Screening Tool for Patients Without Diabetes Of patients with preop glucose > 100, 15% were diagnosed with diabetes within one year, but 85% were not. Wang. J Surg Res. 2014; 186: 371-8

Can we do anything before the operation to reduce the risk of hyperglycemia and its associated complications?

PreOp CHO and Insulin Resistance 474 ml evening, 237 ml 3 h Preop Control CHO p HOMA-IR 5.74 2.75 0.03 Insulin 19.9 10.7 0.05 Glucose 115 105 0.09 Perrone. Nutrition Journal 2011; 10: 66

Gastric Emptying After 400 ml CHO Drink in Diabetics Insulin treated diabetics Oral/diet treated diabetics Healthy subjects Gustafsson. ActaAnaesthScand 2008; 52: 946-51

400 ml CHO Drink 50 g CHO 12% monosaccharides 12% disaccharides 76% polysaccharides 285 mosm Nutricia Preop R Gustafsson. ActaAnaesthScand 2008; 52: 946-51

Cochrane Review on PreOp Fasting There was no evidence to suggest a shortened fluid fast results in an increased risk of aspiration, regurgitation or related morbidity compared with the standard nil by mouth from midnight fasting policy. Permitting patients to drink water preoperatively resulted in significantly lower gastric volumes. Brady M. Cochrane Database Syst Rev 2003; (4).CD004423

PreOp CHO and Muscle Mass Major Abdominal Surgery 800 ml evening, 400 ml 2 h Preop Triceps Skin Fold Arm Muscle Circum Svanfeldt. Br J Surg 2007; 94: 1342-50

PreOp CHO and Insulin Levels Colorectal Surgery, 400 ml 3 h Preop Wang. Br J Surg 2010; 97: 317-27

PreOp CHO and Glucose Levels Colorectal Surgery, 400 ml 3 h Preop Wang. Br J Surg 2010; 97: 317-27

PreOp CHO and Insulin Resistance Colorectal Surgery, 400 ml 3 h Preop Wang. Br J Surg 2010; 97: 317-27

PreOp CHO, Gastric Volume & ph Colorectal Surgery, 400 ml 2 h Preop Measured Immediately After Induction ph Volume, ml Yagci. Nutrition 2008; 24: 212-6

Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology 2011;114:495-511 It is appropriate to fast from intake of clear liquids at least 2 h before elective procedures requiring general anesthesia, regional anesthesia, or sedation/analgesia. Examples of clear liquids include, but are not limited to, water, fruit juices without pulp, carbonated beverages, clear tea, and black coffee.... The volume of liquid ingested is less important than the type of liquid ingested.

SCOAP Adverse Events with Hyperglycemia Diabetics v. NonDiabetics Kotagal. Ann Surg 2015; 261:97-103

SCOAP Adverse Events with Hyperglycemia Diabetics v. NonDiabetics Kotagal. Ann Surg 2015; 261:97-103

Perioperative Blood Glucose at UWMC Amalga data Inpatient ops, 7/1/13 7/30/15 11,079 Nondiabetics among those 8,974 (81%) Nondiabetics with gluc > 140 mg% day of op 2,929 (33%) Nondiabetics with gluc > 140 mg%, day 0-2 4,834 (54%) Data courtesy of Ray Bunnage, Center for Clinical Excellence

Glucose Levels & SSI The exact best level of glucose control in the perioperative period is not known. High glucose levels unequivocally increase the risk of SSI and other perioperative infections. Tight glucose control in the perioperative period is tricky. Hypoglycemia increases the risk of morbidity and mortality. Some examples of successful glucose control programs follow.

GLUCOSE CONTROL ALGORITHMS The Rabbit 2 basal bolus protocol is online at http://care.diabetesjournals.org/lookup/su ppl/doi:10.2337/dc10-1407/-/dc1 The Society of Hospital Medicine Glycemic Control Resource room contains links to multiple insulin infusion protocols at http://www.hospitalmedicine.org/resourc eroomredesign/html/12clinical_tools/04 _Insulin_OrdersIV.cfm